Naloxone for In-Hospital Cardiac Arrest
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 850 participants.
Also called NCT07806565
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 850 participants
- Sponsor
- Registry
-
NCT07806565 -
2026-525323-24-00
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07806565. Randomized; quadruple masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2030-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Naloxone for In-Hospital Cardiac Arrest
- Acronym
- naloxone-IHCA
- Condition
- Heart Arrest
- Intervention (Drug)
- naloxone
- Intervention (Drug)
- Placebo
- Lead sponsor
- Region Skane
- Collaborator
- Lund University
- Collaborator
- Clinical Studies Sweden
- Collaborator
- Copenhagen Trial Unit, Center for Clinical Intervention Research
Record details
- Record id
cardio:ct-nct07806565- Content hash
3c2d95a3e1dd740430146568522d09da749318e25b8177673cd01a8f6d9b2042